- Home
- GERN vs ESBA Comparison
GERN vs ESBA Comparison
Compare GERN & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- ESBA
- Stock Information
- Founded
- GERN 1990
- ESBA N/A
- Country
- GERN United States
- ESBA United States
- Employees
- GERN N/A
- ESBA N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- ESBA
- Sector
- GERN Health Care
- ESBA
- Exchange
- GERN Nasdaq
- ESBA NYSE
- Market Cap
- GERN 2.5B
- ESBA 2.9B
- IPO Year
- GERN 1996
- ESBA 2013
- Fundamental
- Price
- GERN $3.93
- ESBA $10.91
- Analyst Decision
- GERN Strong Buy
- ESBA
- Analyst Count
- GERN 10
- ESBA 0
- Target Price
- GERN $7.05
- ESBA N/A
- AVG Volume (30 Days)
- GERN 6.7M
- ESBA 10.4K
- Earning Date
- GERN 11-07-2024
- ESBA 01-01-0001
- Dividend Yield
- GERN N/A
- ESBA 1.27%
- EPS Growth
- GERN N/A
- ESBA N/A
- EPS
- GERN N/A
- ESBA 0.27
- Revenue
- GERN $29,480,000.00
- ESBA $758,432,000.00
- Revenue This Year
- GERN $32,021.10
- ESBA N/A
- Revenue Next Year
- GERN $298.14
- ESBA N/A
- P/E Ratio
- GERN N/A
- ESBA $40.70
- Revenue Growth
- GERN 9199.68
- ESBA 4.19
- 52 Week Low
- GERN $1.64
- ESBA $7.85
- 52 Week High
- GERN $5.34
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- GERN 46.32
- ESBA 51.53
- Support Level
- GERN $3.75
- ESBA $10.80
- Resistance Level
- GERN $4.05
- ESBA $11.10
- Average True Range (ATR)
- GERN 0.16
- ESBA 0.17
- MACD
- GERN -0.01
- ESBA 0.01
- Stochastic Oscillator
- GERN 39.13
- ESBA 50.66
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is the operating partner of Empire State Realty Inc. The company along with its partner manages, operates, acquires and repositions properties in Manhattan and the greater New York metropolitan area. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.